Aquestive Therapeutics, Inc. AQST Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s earnings yield?
- Aquestive Therapeutics, Inc. (AQST) reported earnings yield of -13.6% in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s earnings yield changed year-over-year?
- Aquestive Therapeutics, Inc.'s earnings yield increased by 28.1% year-over-year, from -18.9% to -13.6%.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s earnings yield has grown at a -16.4% compound annual growth rate (CAGR), from -26% to -10.6%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.